Incidence and Risk Factors of Early Onset Neonatal AKI

Neonatal Kidney Collaborative

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND AND OBJECTIVES: Neonatal AKI is associated with poor short- and long-term outcomes. The objective of this study was to describe the risk factors and outcomes of neonatal AKI in the first postnatal week. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The international retrospective observational cohort study, Assessment of Worldwide AKI Epidemiology in Neonates (AWAKEN), included neonates admitted to a neonatal intensive care unit who received at least 48 hours of intravenous fluids. Early AKI was defined by an increase in serum creatinine >0.3 mg/dl or urine output <1 ml/kg per hour on postnatal days 2-7, the neonatal modification of Kidney Disease: Improving Global Outcomes criteria. We assessed risk factors for AKI and associations of AKI with death and duration of hospitalization. RESULTS: Twenty-one percent (449 of 2110) experienced early AKI. Early AKI was associated with higher risk of death (adjusted odds ratio, 2.8; 95% confidence interval, 1.7 to 4.7) and longer duration of hospitalization (parameter estimate: 7.3 days 95% confidence interval, 4.7 to 10.0), adjusting for neonatal and maternal factors along with medication exposures. Factors associated with a higher risk of AKI included: outborn delivery; resuscitation with epinephrine; admission diagnosis of hyperbilirubinemia, inborn errors of metabolism, or surgical need; frequent kidney function surveillance; and admission to a children's hospital. Those factors that were associated with a lower risk included multiple gestations, cesarean section, and exposures to antimicrobials, methylxanthines, diuretics, and vasopressors. Risk factors varied by gestational age strata. CONCLUSIONS: AKI in the first postnatal week is common and associated with death and longer duration of hospitalization. The AWAKEN study demonstrates a number of specific risk factors that should serve as "red flags" for clinicians at the initiation of the neonatal intensive care unit course. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Assessment of Worldwide AKI Epidemiology in Neonates (AWAKEN), NCT02443389.

Original languageEnglish (US)
Pages (from-to)1
Number of pages1
JournalClinical journal of the American Society of Nephrology : CJASN
Volume2019
Issue number2
DOIs
StatePublished - Oct 1 2019

Keywords

  • Acute Kidney Injury
  • Anti-Infective Agents
  • Cesarean Section
  • child
  • Children
  • creatinine
  • diuretics
  • Epinephrine
  • Gestational Age
  • hospitalization
  • Hyperbilirubinemia
  • Incidence
  • Infant
  • Intensive Care Units
  • Mating Factor
  • methylxanthine
  • Neonatal
  • neonatal kidney collaborative
  • Newborn
  • Pregnancy
  • Retrospective Studies
  • risk factors
  • Vasoconstrictor Agents
  • Xanthines

ASJC Scopus subject areas

  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Nephrology
  • Transplantation

Fingerprint

Dive into the research topics of 'Incidence and Risk Factors of Early Onset Neonatal AKI'. Together they form a unique fingerprint.

Cite this